跳至主要内容
临床试验/NCT04346186
NCT04346186已完成不适用

COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff

Herlev Hospital14 个研究点 分布在 1 个国家目标入组 44,698 人开始时间: 2020年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
44,698
试验地点
14
主要终点
Comparison of the point of care test and Elisa

研究概览

简要总结

During the COVID-19 pandemic several countries have seen a high risk of transmission for health care personnel, with some countries having as many 20-25% of nurses and doctors either infected or showing symptoms of COVID-19.

In this prospective cohort study, we will systematically screen all hospital staff in the Capital Region of Denmark for IgM and IgG antibodies against SARS-CoV-2 using a point of care tests and an Elisa kit.

Testing will be offered 3 times: In April 2020, Maj 2020 and September 2020. All participants will submit a questionnaire regarding exposures, risk factors and symptoms of COVID-19 in relation to each testing. Follow-up will be through electronic patient records and national registries.

We will compare the group of health care personnel with data from a control group of healthy volunteer blood donors from the Danish Blood Donor Study.

The aim of the study is to investigate the proportion of hospital staff with SARS-CoV-2 antibodies during the study period compared to a control group representing the Danish population. We will compare the test characteristics of the two methods of testing, a point of care test and Elisa.

Further, we will investigate the extent to which prior immunization or infection is protective for future infection with COVID-19.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • >18 years old
  • Consent to participation
  • Employed at a Hospital in the Capitial Region of Denmark

排除标准

  • 未提供

结局指标

主要结局

Comparison of the point of care test and Elisa

时间窗: 5 months

Comparison of the resultat from the point of care test and with results from Elisa

Re-infection rate

时间窗: 360 days

Number of patients, who were tested positive for antibodies on an earlier test and later are infected with COVID-19

Positive IgM/IgG tests

时间窗: 5 month

Proportion of hospital staff who have a positive IgM/IgG tests for antibodies to SARS-CoV-2 on point of care test and/or Elisa compared to the background population

IgM/IgG positive participants on follow-up test

时间窗: 5 months

Proportion of IgM/IgG positive participants with a lasting immune response. This will be the participants who are still positive on follow-up

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kasper Iversen

Professor

Herlev Hospital

研究点 (14)

Loading locations...

相似试验